Reby Advisors’s Gilead Sciences GILD Stock Holding History

Reby Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$37K	Buy	+630	New	+$38K	0.01%	260

Other funds holding GILD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Reby Advisors's GILD Position: Q4 2020 in Review

Reby Advisors opened a new position in Gilead Sciences (GILD) in Q4 2020: 630 shares worth $37K. The stake represents 0.01% of the portfolio and ranks #260 among its holdings.

1,563 funds tracked by Wall St. Rank hold GILD as of Q4 2020.

Reby Advisors held 630 shares of Gilead Sciences worth $37K as of Q4 2020.
Gilead Sciences was a new Reby Advisors position in Q4 2020.
Gilead Sciences made up 0.01% of Reby Advisors's portfolio in Q4 2020, its #260 holding.
1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.

Based on Reby Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.